Skip to main content
Log in

The EMA's CHMP has finalised a review of recently published information on the cardiovascular (CV) safety of NSAIDs,

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. EMA.European Medicines Agency finalises review of recent published data on cardiovascular safety of NSAIDs. Media Release: 19 Oct 2012. Available from: URL: http://www.ema.europa.eu

  2. EMA.Questions and answers on the review of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and cardiovascular risk. Internet Document: [3 pages], 18 Oct 2012. Available from: URL: http://www.ema.europa.eu

Download references

Additional information

Key words

Pharmacovigilance; adverse reactions; Cardiovascular-disorders; Diclofenac; drug-induced; Nonsteroidal-anti-inflammatories

Rights and permissions

Reprints and permissions

About this article

Cite this article

The EMA's CHMP has finalised a review of recently published information on the cardiovascular (CV) safety of NSAIDs,. React. Wkly. 1426, 2 (2012). https://doi.org/10.2165/00128415-201214260-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214260-00002

Keywords

Navigation